American Journal of Psychiatry Audio Podcast By American Journal of Psychiatry cover art

American Journal of Psychiatry Audio

American Journal of Psychiatry Audio

By: American Journal of Psychiatry
Listen for free

Each episode of AJP Audio brings you an in-depth look at one of the articles featured in that month's issue of The American Journal of Psychiatry, the official journal of the American Psychiatric Association. Wide-ranging interviews with article authors cover the background, rationale, main findings, and future implications of the research. This podcast is subject to the Terms of Use at ww.psychiatry.org. The views and opinions expressed in this podcast are those of the individual speakers only and do not necessarily represent the views of the American Psychiatric Association, its officers, trustees, or members. The content of this podcast is provided for general informational purposes only and is not intended as, and shall not be understood or construed as, medical or any other type of professional advice nor does it represent any statement of the standard of care. We strongly recommend that any listener follow the advice of physicians directly involved in their care and contact their local emergency response number for any medical emergency. The information within this podcast is provided as-is and is not guaranteed to be correct, complete, or accurate.Copyright 2021 American Psychiatric Association Hygiene & Healthy Living Physical Illness & Disease Science
Episodes
  • April 2026: Mobile Health for Alcohol Use Assessment: Longitudinal Effects of Breathalyzer Self-Monitoring in Everyday Contexts
    Apr 1 2026

    Yang Lu, M.S., and Catharine E. Fairbairn, Ph.D. (University of Illinois, Urbana-Champaign) join AJP Audio to discuss the longitudinal effects of the use of personal alcohol breathalyzers in a natural setting on alcohol usage. Afterwards, AJP Editor-in-Chief Dr. Ned Kalin joins the podcast to discuss the rest of the April issue, which focuses on subjects related to substance use disorders.

    • 00:57 What did you discover about the long term effects of using a personal blood alcohol monitor?
    • 03:12 Do health monitoring devices actually change behaviors?
    • 04:10 What did your cohort look like?
    • 08:49 Disparate impact of monitoring on heavy drinkers and light drinkers
    • 11:36 Clinical implications
    • 14:34 Limitations
    • 15:46 Avenues for further research
    • 18:39 Kalin interview
    • 18:46 Lu et al.
    • 24:00 Wittekind et al.
    • 29:50 Nicholson et al.

    Transcript

    Be sure to let your colleagues know about the podcast, and please rate and review it on Apple Podcasts, Google Podcasts, Spotify, or wherever you listen to it.

    Subscribe to the podcast here.

    Listen to other podcasts produced by the American Psychiatric Association.

    Browse articles online.

    How authors may submit their work.

    Follow the journals of APA Publishing on Twitter.

    E-mail us at ajp@psych.org

    Show more Show less
    36 mins
  • March 2026: Primary Prevention of PTSD Symptoms in Combat-Deploying Soldiers Using Attention Bias Modification: A Randomized Controlled Trial
    Mar 1 2026

    Chelsea Dyan Gober Dykan, M.A. (Tel Aviv University, Israel), joins AJP Audio to discuss a study looking at two versions of attention bias modification with an eye towards a prophylactic impact on developing PTSD in a cohort of combat-bound soldiers. Afterwards, AJP Editor-in-Chief Dr. Ned Kalin joins the podcast to put the rest of the March issue into context.

    • 00:57 Attention bias modifications
    • 03:54 Response-time and gaze-contingent paradigms
    • 05:05 Differences in efficacy between the two arms
    • 08:06 Ethical considerations in investigating combat-bound soldiers
    • 10:44 Controlling for combat experiences in studying PTSD
    • 12:24 Duration of the effect
    • 13:44 Limitations
    • 15:03 Immediate clinical implications
    • 16:22 Further research
    • 17:05 Kalin interview
    • 17:22 Dykan et al.
    • 21:03 Kaul et al.
    • 26:19 Kantrowitz et al.

    Transcript

    Be sure to let your colleagues know about the podcast, and please rate and review it on Apple Podcasts, Google Podcasts, Spotify, or wherever you listen to it.

    Subscribe to the podcast here.

    Listen to other podcasts produced by the American Psychiatric Association.

    Browse articles online.

    How authors may submit their work.

    Follow the journals of APA Publishing on Twitter.

    E-mail us at ajp@psych.org

    Show more Show less
    33 mins
  • February 2026: Doxycycline Use in Adolescent Psychiatric Patients and Risk of Schizophrenia: An Emulated Target Trial
    Feb 1 2026

    Dr. Ian Kelleher (University of Edinburgh, Scotland) joins AJP Audio to discuss an emulated target trial looking at the prophylactic qualities of doxycycline, an antibiotic, in an adolescent population at risk to develop schizophrenia spectrum disorder. Afterwards, AJP Editor-in-Chief Dr. Ned Kalin joins the podcast to put the rest of the issue into context.

    • 00:53 Doxycycline and the risk of developing schizophrenia
    • 04:03 Emulated target trials versus randomized control trials
    • 06:43 Methods of action
    • 09:24 Dosage and exposure levels for doxycycline
    • 10:15 Immediate clinical applications
    • 10:56 Limitations of the study
    • 11:33 Future research
    • 12:43 Kalin interview
    • 13:00 Lång et al.
    • 19:43 Zhao et al.
    • 25:20 Metrik et al.

    Transcript

    Be sure to let your colleagues know about the podcast, and please rate and review it on Apple Podcasts, Google Podcasts, Spotify, or wherever you listen to it.

    Subscribe to the podcast here.

    Listen to other podcasts produced by the American Psychiatric Association.

    Browse articles online.

    How authors may submit their work.

    Follow the journals of APA Publishing on Twitter.

    E-mail us at ajp@psych.org

    Show more Show less
    30 mins
All stars
Most relevant
very helpful and eye opening! I loved the insights into clinical practice! Thank you so much!

awesome!

Something went wrong. Please try again in a few minutes.